Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer

被引：0
|
作者：
Yen-Shen Lu
Dar-Ren Chen
Ling-Min Tseng
Dah-Cherng Yeh
Shou-Tung Chen
Chia-Ming Hsieh
Hwei-Chung Wang
Hsien-Tang Yeh
Sung-Hsin Kuo
Chiun-Sheng Huang
机构：
[1] National Taiwan University Hospital,Department of Oncology
[2] Changhua Christian Hospital,Department of Surgery
[3] Taipei Veterans General Hospital and National Yang-Ming University,Department of Surgery
[4] Taichung Veterans General Hospital,Department of Surgery
[5] Taiwan Adventist Hospital,Department of Surgery
[6] China Medical University Hospital,Department of Surgery
[7] Lotung Poh-Ai Hospital,Department of Surgery
[8] National Taiwan University Hospital,Department of Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 67卷
关键词：
Locally advanced breast cancer; Neoadjuvant chemotherapy; Docetaxel; Cisplatin; Capecitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1257 / 1263
页数：6
相关论文
共 50 条
  • [1] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Lu, Yen-Shen
    Chen, Dar-Ren
    Tseng, Ling-Min
    Yeh, Dah-Cherng
    Chen, Shou-Tung
    Hsieh, Chia-Ming
    Wang, Hwei-Chung
    Yeh, Hsien-Tang
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1257 - 1263
  • [2] A phase II trial of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.
    Lu, YS
    Kuo, SH
    Su, WP
    Yang, CH
    Hsu, C
    Yang, TL
    Huang, CS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 93S - 93S
  • [3] A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer
    Villman, Kenneth
    Ohd, John F.
    Lidbrink, Elisabet
    Malmberg, Lena
    Lindh, Birgitta
    Blomqvist, Carl
    Nordgren, Hans
    Bergh, Jonas
    Bergstrom, Daniel
    Ahlgren, Johan
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (07) : 1153 - 1160
  • [4] A phase II trial of Neoadjuvant docetaxel and capecitabine for locally advanced breast cancer
    Lebowitz, PF
    Eng-Wong, J
    Swain, SM
    Berman, A
    Merino, MJ
    Chow, CK
    Venzon, D
    Zia, F
    Danforth, D
    Liu, E
    Zujewski, J
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6764 - 6769
  • [5] Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer
    Al-Tweigeri, Taher A.
    Ajarim, Dahish S.
    Alsayed, Adher A.
    Rahal, Mohamed M.
    Alshabanah, Mohamed O.
    Tulbah, Asma M.
    Al-Malik, Osama A.
    Fatani, Doha M.
    El-Husseiny, Gamal A.
    Elkum, Naser B.
    Ezzat, Adnan A.
    [J]. MEDICAL ONCOLOGY, 2010, 27 (03) : 571 - 577
  • [6] Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer
    Taher A. Al-Tweigeri
    Dahish S. Ajarim
    Adher A. Alsayed
    Mohamed M. Rahal
    Mohamed O. Alshabanah
    Asma M. Tulbah
    Osama A. Al-Malik
    Doha M. Fatani
    Gamal A. El-Husseiny
    Naser B. Elkum
    Adnan A. Ezzat
    [J]. Medical Oncology, 2010, 27 : 571 - 577
  • [7] Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Perez Manga, Gumersindo
    Khosravi Shahi, Parham
    Mendez Urena, Miguel
    Quiben Pereira, Rosa
    Palomero Plaza, Maria Isabel
    Izarzugaza Peron, Yann
    Gonzalez Del Val, Ricardo
    Belon Carrion, Joaquin
    Perez Canon, Esperanza
    Garcia Alfonso, Pilar
    [J]. BREAST CANCER, 2010, 17 (03) : 205 - 211
  • [8] Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Gumersindo Pérez Manga
    Parham Khosravi Shahi
    Miguel Méndez Ureña
    Rosa Quiben Pereira
    María Isabel Palomero Plaza
    Yann Izarzugaza Peron
    Ricardo González Del Val
    Joaquín Belón Carrión
    Esperanza Pérez Cañón
    Pilar García Alfonso
    [J]. Breast Cancer, 2010, 17 : 205 - 211
  • [9] Phase II study of neoadjuvant treatment with docetaxel, doxorubicin and capecitabine (ATX) in locally advanced or inflammatory breast cancer
    Khosravi-Shahi, P.
    Mendez, M.
    Quiben, R.
    Palomero, I.
    Izarzugaza, Y.
    Belon, J.
    Garcia-Alfonso, P.
    Perez-Manga, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study
    Yu, Deguo
    Wang, Zhenfeng
    He, Tingbang
    Yang, Lijun
    [J]. FRONTIERS IN SURGERY, 2022, 9
12345